[144] Life360, Inc. SEC Filing
Rhea-AI Filing Summary
Form 144 filed for Life360, Inc. (LIF) reporting a proposed sale of 500 common shares to be executed approximately on 08/25/2025 through Fidelity Brokerage Services. The shares were acquired on 09/19/2024 upon restricted stock vesting and were issued as compensation. The filing lists 77,548,651 shares outstanding for the issuer and an aggregate market value for the proposed sale of $45,000.00.
The filing also discloses prior sales by the same person during the past three months totaling 6,387 shares with gross proceeds of $419,445.40, consisting of multiple transactions between 05/27/2025 and 08/11/2025. The filer certifies they are not aware of any undisclosed material adverse information about the issuer.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine insider Rule 144 notice for a small proposed sale relative to outstanding shares.
The Form 144 documents a proposed sale of 500 common shares by an insider, acquired through restricted stock vesting and designated as compensation. The proposed transaction value ($45,000) and the recent sales history (6,387 shares, $419,445.40) are small relative to the issuer's stated outstanding share count (77,548,651), indicating limited dilution or market impact. The filing meets disclosure requirements under Rule 144 by providing acquisition detail, broker information, and a representation about material non-public information.
TL;DR: Disclosure appears compliant and routine; no red flags in the notice itself.
The notice specifies the acquisition date, nature (restricted stock vesting), and payment nature (compensation), and identifies the broker and planned sale date. Multiple recent sales by the same person are listed, showing the insider has been selling vested shares over several months. The filer affirms absence of undisclosed material adverse information. From a governance perspective, the document is a standard compliance filing rather than an indicator of governance change.